Ascendis Pharma Earnings Yield Over Time
| ASND Stock | USD 130.85 1.04 0.80% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Ascendis Pharma Performance and Ascendis Pharma Correlation. Ascendis |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ascendis Pharma. If investors know Ascendis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ascendis Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.81) | Revenue Per Share 5.595 | Quarterly Revenue Growth (0.24) | Return On Assets (0.28) | Return On Equity (8.18) |
The market value of Ascendis Pharma AS is measured differently than its book value, which is the value of Ascendis that is recorded on the company's balance sheet. Investors also form their own opinion of Ascendis Pharma's value that differs from its market value or its book value, called intrinsic value, which is Ascendis Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ascendis Pharma's market value can be influenced by many factors that don't directly affect Ascendis Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ascendis Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascendis Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascendis Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Earnings Yield Analysis
Compare Ascendis Pharma AS and related stocks such as Eliem Therapeutics, HCW Biologics, and Scpharmaceuticals Earnings Yield Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCWB | (0.0312) | (0.0312) | (0.0312) | (0.0312) | (0.0312) | (0.0312) | (0.0312) | (0.0312) | (0.0312) | (0.0312) | (0.025) | (0.1489) | (0.2146) | (0.5656) | (0.54) |
| SCPH | (0.0666) | (0.0666) | (0.0666) | (0.0666) | (0.0666) | (0.0666) | (0.1543) | (0.6649) | (0.422) | (0.3269) | (0.2646) | (0.222) | (0.1845) | (0.227) | (0.24) |
| MIST | (0.0222) | (0.0222) | (0.0222) | (0.0222) | (0.0222) | (0.0222) | (0.0222) | (0.0222) | (0.0638) | (0.2185) | (0.2541) | (0.1556) | (0.3399) | (0.832) | (0.79) |
| MCRB | (0.0029) | (0.0029) | (0.0029) | (0.004) | (0.0109) | (0.0663) | (0.2321) | (0.2179) | (0.5373) | (0.3287) | (0.0442) | (0.0805) | (0.4194) | (0.6346) | (0.6) |
| LUMO | (0.8102) | (3.8128) | (0.8081) | (0.5044) | 0.8366 | (0.3494) | (2.5726) | (2.5507) | (8.5326) | (117) | (0.0234) | (0.5269) | (1.0275) | (1.314) | (1.38) |
Ascendis Pharma AS and related stocks such as Eliem Therapeutics, HCW Biologics, and Scpharmaceuticals Earnings Yield description
The inverse of the price-to-earnings ratio, representing the percentage of each dollar invested in the stock that was earned by the company.My Equities
My Current Equities and Potential Positions
| Ascendis Pharma AS | ASND |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Denmark |
| Exchange | NASDAQ Exchange |
USD 130.85
Check out Ascendis Pharma Performance and Ascendis Pharma Correlation. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Ascendis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.